Mary Beth Harler Insider Profile

4 Followers
Mary Beth Harler, Head, Research & Autoimmunity at IGM Biosciences, holds 165.23K shares in IGM Biosciences (Ticker: IGMS).
tipranks
Mary Beth Harler

Mary Beth Harler
IGM Biosciences (IGMS)
Head, Research & Autoimmunity

Not Ranked
Mary Beth Harler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Mary Beth Harler's holdings

Insider Roles

IGM Biosciences
(IGMS)
Head, Research & Autoimmunity
Roles that Mary Beth Harler holds in companies

Most Profitable Insider Trade

Stock:
IGM Biosciences
(IGMS)
Rating:Informative Sell
Date:Jun 18, 2024 - Today
Return:-26.30%
The most profitable trade made by Mary Beth Harler

Mary Beth Harler's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IGM Biosciences
Jul 23, 2024
Head, Research & Autoimmunity
Uninformative Buy
$1.79M
Success Rate for
IGMS
0 out of 1 profitable transactions on
IGMS
0%
Average Return for
IGMS
Average return per transaction on
IGMS
-26.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 23, 2024
Uninformative Buy
$0.00
-
$0.00
Jun 18, 2024
Informative Sell
$11.88K
-
$7.57
-26.30%
List of latest transactions for each holding click on a transaction to see Mary Beth Harler's performance on stock

Mary Beth Harler insider profile FAQ

What is the percentage of profitable transactions made by Mary Beth Harler?
The percentage of profitable transactions made by Mary Beth Harler is ―.
    What is the average return per transaction made by Mary Beth Harler?
    The average return per transaction made by Mary Beth Harler is ―.
      What stocks does Mary Beth Harler hold?
      Mary Beth Harler holds: IGMS stocks.
        What was Mary Beth Harler’s latest transaction?
        Mary Beth Harler latest transaction was an Uninformative Buy of ―.
          What was Mary Beth Harler's most profitable transaction?
          Mary Beth Harler’s most profitable transaction was an Informative Sell of IGMS stock on June 18, 2024. The return on the trade was -26.30%.
            What is Mary Beth Harler's role in IGM Biosciences?
            Mary Beth Harler's role in IGM Biosciences is Head, Research & Autoimmunity.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.